Consumer health products containing cannabinoids and deemed unapproved drugs in the US aren’t limited to products marketed as dietary supplements. The Food and Drug Administration has warned a contract manufacturer and another firm about making OTC drugs with cannabinoids.
The firms, BioLyte Laboratories LLC and Honest Globe Inc., also were advised by the FDA’s Office of Regulatory Affairs Division...



